In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is urging WHO and member states, as part of the WHO road map for neglected tropical diseases (NTDs), to address key gaps is our arsenal of NTD interventions—including diagnostic, treatments, and pediatric therapies—by increasing investments in NTD R&D and improving WHO guidance and regulatory processes for in-vitro diagnostics.
News & Insights
Check out the latest news and announcements from GHTC.
In advance of the 150th session of the World Health Organization (WHO) Executive Board, GHTC is calling on WHO and member states to increase investments in tuberculosis (TB) R&D, enhance protocol coordination and data sharing platforms, and streamline guidance processes for new tools to accelerate the development of and equitable access to TB products.
- In the media
Latest from the Breakthroughs Blog
Read stories about bright ideas and bold innovations in global health.
Research Roundup: Preventive antibodies for malaria, injectable PrEP, and an intranasal COVID-19 vaccine
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Learn more about upcoming events hosted by or featuring GHTC and its members.
- GHTC event